Publications and Presentations Featuring Spero Therapeutics Drug Candidates and Research

Browse through key publications and presentations that have discussed our drug candidates and our work involving the treatment of bacterial infections.

Presentation Categories

Oral 4
Poster 82
Written 13
Select All

In Vitro Susceptibility Testing of a Novel Benzimidazole, SPR719, Against Nontuberculous Mycobacteria

October 24, 2018

American Society for Microbiology Journals, DOI: 10.1128/AAC.01503-18 Barbara A. Brown-Elliott, Aileen Rubio, Richard J. Wallace, Jr.

Patient Demographics And Comorbidity Profiles Associated With Hospitalized Patients Admitted With Resistant Versus Susceptible Urinary Tract Infections (UTI): A Multicenter Analysis

October 05, 2018

Characterization of SPR994, an Orally Available Carbapenem, with Activity Comparable to Intravenously Administered Carbapenems

August 17, 2018

ACS Infect. Dis., DOI: 10.1021/acsinfecdis.8b00188 Aileen Rubio, Michael J. Pucci, and Akash Jain

Tebipenem, the First Oral Carbapenem Antibiotic

July 27, 2018

Expert Review of Anti-infective Therapy, DOI: 10.1080/14787210.2018.1496821 Michael J. Pucci, Akash Jain, Luke Utley, Thomas Zabawa & Thomas R. Parr

Assessment of the In Vivo Activity of SPR741 in Combination with Azithromycin against Multidrug Resistant Enterobacteriaceae isolates in the Neutropenic Murine Thigh Infection model

June 26, 2018

Antimicrobial Agents and Chemotherapy, 2018 Jun 26;62(7). pii: e00239-18. DOI: 10.1128/AAC.00239-18. Print 2018 Jul Stainton SM, Abdelraouf K, Utley L, Pucci MJ, Lister T, Nicolau DP.

Pages: First Page123456789101112131415161718192021222324Last Page

Publications and Presentations Featuring Spero Therapeutics Drug Candidates and Research

Presentation Categories

Presentation Tags